Skip to main content

Alimera Sciences Inc. Common Stock (ALIM)

About The Company

ALIM Stock Market Logo

Alimera Sciences is a pharmaceutical company focused on commercializing and developing treatments that address diseases affecting the back of the eye (retina). ILUVIEN(R) is Alimera’s a patented micro-implant which delivers a continuous, low dose anti-inflammatory agent to the retina for up to 3 years. A $2B global market, DME is often treated with acute therapies when the fluid in the eye returns. ILUVIEN reduces the recurrence of edema leading to stablevision, with the benefit of continuous treatment due to the product’s novel drug delivery technology.

IPO Year Sector Industry
2010 Health Care Biotechnology: Pharmaceutical Preparations

Alimera Sciences Inc. (ALIM) Latest News

Company Contact & Address (ALIM)

Corporate Headquarters Phone Website
6120 WINDWARD PARKWAY SUITE 290,
ALPHARETTA,
Georgia,
30005,
United States
+1 678 990-5740 Official ALIM Website

ALIM Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ALIM

Jobs & Employment at Alimera Sciences Inc.

LinkedIn Company Page https://www.linkedin.com/company/alimera-sciences
Official Career & Employment Page See LinkedIn page for more jobs & employment info.

Related & Similar Stock Symbols

PFE Stock Market Price & News

PFE

Pfizer Inc. Common Stock

RYAN Stock Market Price & News

RYAN

Ryan Specialty Holdings Inc. Class A Common …

TRAQ Stock Market Price & News

TRAQ

Trine II Acquisition Corp. Class A Ordinary …